52岁男性锁骨骨膜下软骨黏液样纤维瘤一例
报告一例52岁男性锁骨骨干骨膜下软骨黏液样纤维瘤,病灶5年内缓慢增大。MRI显示T2显著高信号和明显强化,经手术刮除后行GRM1免疫组化确诊,术后6个月无复发。GRM1可作为不典型部位CMF的确诊辅助工具。
要点
- 锁骨区边界清楚骨膜下病变伴膨胀性重塑且无骨膜反应时,应把软骨黏液样纤维瘤纳入鉴别。
- T2显著高信号合并明显强化提示软骨性肿瘤,但确诊仍需结合GRM1免疫组化。
- 不典型部位活检组织有限时,加做GRM1免疫组化有助于避免误诊和过度治疗。
核心结论
- GRM1免疫组化可作为确诊软骨黏液样纤维瘤的辅助手段,尤其适用于解剖部位不典型或组织取材有限导致组织学与影像学特征不明确时。
研究设计与样本
- 单病例报告,对象为一名52岁男性锁骨骨干骨膜下软骨黏液样纤维瘤患者,行MRI和手术刮除后组织学及GRM1免疫组化检查。
关键影像表现/征象
- 影像上表现为边界清楚、位于骨膜下的病变,伴膨胀性重塑但无骨膜反应。
- MRI上病灶在T2加权像呈显著高信号,并可见明显对比增强。
- 病灶在5年期间逐渐增大。
诊断标准与关键数值
- 组织学表现为细胞密度不均,星形至梭形细胞位于软骨黏液样基质中,单核细胞密集分布伴偶见破骨细胞样巨细胞,呈模糊分叶状排列。
- 免疫组化GRM1阳性可确认软骨黏液样纤维瘤诊断。
临床应用与阅片要点
- 对锁骨区不典型骨膜下病变,阅片时应关注T2显著高信号与明显强化,并与GRM1免疫组化结果整合以作出诊断。
- 膨胀性重塑且无骨膜反应提示低度或良性病变,避免直接按恶性骨肿瘤处理。
局限性
- 该研究为单病例报告,无法评估GRM1免疫组化在锁骨软骨黏液样纤维瘤中的总体敏感度和特异度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Chondromyxoid fibroma (CMF) is a benign cartilaginous neoplasm that accounts for less than 1% of all primary bone tumors and typically arises in the metaphysis of long bones in young adults. CMF occurring in the clavicle is uncommon, and preoperative diagnosis can be challenging. We report a case of CMF arising in the subperiosteal region of the clavicular diaphysis in a 52-year-old man. Radiologically, a well-defined, subperiosteal lesion with expansile remodeling but without periosteal reaction was identified, showing marked hyperintensity on T2-weighted magnetic resonance imaging and intense contrast enhancement. The lesion gradually increased in size over a 5-year period, prompting surgical curettage. Histologically, the tumor showed heterogeneous cellularity, with stellate to spindle-shaped cells in a chondromyxoid matrix and densely distributed mononuclear cells with occasional osteoclastic giant cells, arranged in a vaguely lobulated pattern. Immunohistochemical positivity for GRM1 confirmed the diagnosis of CMF. Postoperative follow-up revealed no recurrence at 6 months. Only 14 cases of clavicular CMF have been reported in the literature, to the best of our knowledge. This case is unique because of its subperiosteal diaphyseal location and prolonged radiological observation prior to surgery. Integration of radiological findings with molecular and immunohistochemical evidence, such as GRM1 overexpression, is essential for establishing a definitive diagnosis and avoiding overtreatment in rare tumors with atypical presentations. The present case highlights the diagnostic utility of GRM1 immunohistochemistry as an ancillary tool for confirming CMF, particularly when histological and radiological features are inconclusive because of an unusual anatomical location or limited tissue sampling.
引用
- Nakajima, Iraha, Kawamitsu, et al. A case of subperiosteal clavicular chondromyxoid fibroma in a 52-year-old man: emphasis on diagnostic utility of GRM1 immunohistochemistry. Skeletal Radiol. 2026. PMID: 42680879. doi:10.1007/s00256-026-05361-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。